Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIMAT-MS
DRKS00008037Phase 4Recruiting
- Sponsor
- Universitätsklinikum Münster
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dimethyl fumarate in multiple sclerosis (MS) (2 arms), sponsored by Universitätsklinikum Münster. Started May 2015; status: recruiting.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on DRKS00008037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00008037.